Dr. Seth K. Bechis, MD

Dr. Bechis practices at UCSD Hillcrest Medical Center in San Diego, California.

Dr. Bechis' NPI, 1376863746, was assigned on June 8, 2010. Dr. Bechis graduated from UCSF School of Medicine in 2010. Dr. Bechis holds California license A139139.

Dr. Bechis' primary practice is UCSD Hillcrest Medical Center, at 200 W Arbor Dr, San Diego, CA 92103 in San Diego County. The practice phone is (619) 543-6222.

Dr. Bechis' primary practice is UCSD Hillcrest Medical Center in San Diego, California. Dr. Bechis is also affiliated with Hillcrest Medical Center. The medical group on file is UC San Diego Health.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Bechis practices. Vendor and product names are available with a free account.

Urology is Dr. Bechis' primary specialty in the NPI Registry, under taxonomy code 208800000X. Dr. Bechis is board certified in urology by the American Board of Urology. Dmand AI has Dr. Bechis' licenses on file in 2 states: California and Massachusetts.

Dmand AI lists bladder disease, enlarged prostate, enlarged prostate transurethral surgery (TURP), erectile dysfunction, kidney cysts, kidney disease, kidney removal surgery and kidney stone disease among the conditions Dr. Bechis treats.

CMS data shows 1,305 Medicare services from Dr. Bechis across 17 procedure codes in 2024, for 438 Medicare patients. Medicare paid $134,768 for them.

CMS counts 438 Medicare patients who saw Dr. Bechis in 2024. The largest group is 65 to 74, with 208 patients. 75% of them have high cholesterol, and 68% have high blood pressure. 22% are also on Medicaid. Their average risk score is 1.50, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Bechis' median patient age at 67, with 27% women.

In 2024, Dr. Bechis wrote 924 Medicare Part D claims for 306 patients. 84% of them were for generic drugs. CMS names the drug for 846 of them, across 14 drugs with 11 or more claims each, at $123,946 in total drug cost. In 2023, CMS named 728 claims across 13 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 91 out of 100 for Dr. Bechis for performance year 2024, reported as part of a group. Dr. Bechis accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Bechis as offering telehealth. CMS counts 22 procedures of prostate resection by Dr. Bechis, more than 84% of the clinicians it reports for that procedure.

Dmand AI links 65 papers to Dr. Bechis, published from 2005 to 2025. 2020 was the busiest year, with 12. The most frequent topics are Kidney Calculi, Nephrolithotomy, Percutaneous and Prostatic Hyperplasia. Dr. Bechis has published most often in J Endourol. Dr. Bechis' most frequent co-authors are Roger Lu Sur, MD, Jonathan Henry Berger, MD and Naeem Bhojani, MD.

Dmand AI links Dr. Bechis to 3 clinical trials. Conditions studied include Kidney Calculi, Urinary Calculi and Urolithiasis. University of California, San Diego sponsors the most, 2.

CMS Open Payments shows 573 general payments to Dr. Bechis from 44 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 48% of the total. Boston Scientific Corporation paid the most, $227,814. It also lists 1 research payment totaling $4,945 in 2025.

Dmand AI lists 2 awards for Dr. Bechis, most recently Plenary Address for Best Abstract in 2015.

Dr. Bechis graduated from UCSF School of Medicine in 2010. Dr. Bechis is a member of American Association of Clinical Urologists, AUA, Endourology Society and Western Section of the American Urological Association.

Dr. Bechis is in network with 18 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.